FDA 483 - Alembic Pharmaceuticals Limited - August 30, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Alembic Pharmaceuticals Limited, a sterile pharmaceutical manufacturer in Vadodara, Gujarat, India, revealed two significant observations. The firm's aseptic processing areas were found to have deficient air supply due to inadequate airflow visualization studies. Additionally, the company failed to properly record and justify deviations from written procedures, with multiple investigations lacking appropriate preventative actions to prevent reoccurrence.
ID · f9f7f10d-6f7d-44d0-a2e9-ca84399aed37